Clinical Trial Update: Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating neoadjuvant chemotherapy with or without HCW9218 for metastatic advanced ovarian cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• HCW9218

Snippet

Sponsor: Haider Mahdi | Conditions: Ovarian Cancer | Phase 2 | Status: WITHDRAWN